Amalus Therapeutics
We convert the power of selective fibroblast modulation into transformative therapeutics. Pathologically activated fibroblasts orchestrate abnormal tissue structure and drive many diseases. Our technology modulates of disease-associated fibroblasts with unprecedented selectivity, resulting in precise tissue remodeling and normalization, and generating multiple therapeutic benefits.
7-day free trial · no credit card
Verified contacts
6
available on Kipplo
LinkedIn employees
5
1 to 10 range
Open roles
—
no listings
Distinct roles
4
indexed titles
Tech stack
1
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 6 verified contacts at Amalus Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
6 contacts with verified email or phone · masked until revealed.
- MB
Marlies Burgelman
Scientist Biology · Research & Development
EmailPhone - BR
Bart Roman
Chief Executive Officer at Amalus Therapeutics · General Business & Management
EmailPhone - DD
Dominic de Groote
Executive Board Member & Co-founder · General Business & Management
EmailPhone
Showing 3 of 6 verified contacts
Top roles at Amalus Therapeutics
4 distinct titles indexed · top 4 shown.
- 2chief executive officer at amalus therapeutics
- 1assistant
- 1executive board member & co-founder
- 1scientist biology
Sign up to unlock all 6 contacts at Amalus Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 6 verified contacts at Amalus Therapeutics
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.